Stock Scorer
Stock Board CompareNew Screen Insiders ETFNew
Donate
…
Report Measures Companies Earnings calendar Insider buying Fund portfolios Congress trades ETFs
Sign in

Guardian Pharmacy Services, Inc. (GRDN) · Insider trading

What Guardian Pharmacy Services's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$99,786
1 insider, 1 trade
Sold, 12 months
$419.22M
9 insiders, 0% under a plan
Net, 12 months
−$419.12M
bought less sold
Latest filing
2026-09-28
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $148,540 bought 2025-01 2025-05: $338.50M sold 2025-07 2025-12: $99,786 bought 2026-01 2026-03: $419.22M sold 2026-07
Bought Sold Largest month: $419.22M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Bindley William eDirector, 10% owner – $189.85M 3 2026-03-20 –
Bindley Capital Partners I, LLC10% owner – $189.85M 3 2026-03-20 4,469,316
Salentine Thomas J JrDirector, 10% owner – $189.85M 3 2026-03-20 –
Ackerman JohnDirector – $58.67M 6 2026-03-20 –
Pharmacy Investors, LLCOther – $44.00M 3 2026-03-20 1,035,928
Burke FredDirector, See Remarks – $37.79M 3 2026-03-20 840,413
Forbes KendallSee Remarks – $18.66M 3 2026-03-20 453,256
Cardinal Equity Fund, L.P.Other – $14.66M 3 2026-03-20 345,123
Morris David KDirector, See Remarks – $14.40M 3 2026-03-20 254,472
Cosler Steven DDirector $248,326 – 2 2025-12-03 24,984

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-03-20 Cardinal Equity Fund, L.P.Other Sale 275,728 29.68 $8.18M 345,123 Form 4
2026-03-20 Forbes KendallSee Remarks Sale 346,672 29.68 $10.29M 453,256 Form 4
2026-03-20 Bindley William eDirector, 10% owner Saleindirect 3,570,677 29.68 $105.98M 4,469,316 Form 4
2026-03-20 Ackerman JohnDirector Saleindirect 827,636 29.68 $24.56M 1,035,928 Form 4
2026-03-20 Ackerman JohnDirector Saleindirect 275,728 29.68 $8.18M 345,123 Form 4
2026-03-20 Bindley Capital Partners I, LLC10% owner Sale 3,570,677 29.68 $105.98M 4,469,316 Form 4
2026-03-20 Salentine Thomas J JrDirector, 10% owner Saleindirect 3,570,677 29.68 $105.98M 4,469,316 Form 4
2026-03-20 Burke FredDirector, See Remarks Sale 671,432 29.68 $19.93M 840,413 Form 4
2026-03-20 Pharmacy Investors, LLCOther Sale 827,636 29.68 $24.56M 1,035,928 Form 4
2026-03-20 Morris David KDirector, See Remarks Sale 187,855 29.68 $5.58M 254,472 Form 4
2025-12-03 Cosler Steven DDirector Buy 3,370 29.61 $99,786 24,984 Form 4
2025-05-28 Pharmacy Investors, LLCOther Sale 150,998 20.16 $3.04M 449,624 Form 4
2025-05-28 Cardinal Equity Fund, L.P.Other Sale 50,305 20.16 $1.01M 149,794 Form 4
2025-05-28 Bindley Capital Partners I, LLC10% owner Sale 651,454 20.16 $13.13M 1,939,817 Form 4
2025-05-28 Forbes KendallSee Remarks Sale 64,991 20.16 $1.31M 203,906 Form 4
2025-05-28 Burke FredDirector, See Remarks Sale 138,705 20.16 $2.80M 413,019 Form 4
2025-05-28 Morris David KDirector, See Remarks Sale 68,547 20.16 $1.38M 214,495 Form 4
2025-05-28 Ackerman JohnDirector Saleindirect 150,998 20.16 $3.04M 449,624 Form 4
2025-05-28 Ackerman JohnDirector Saleindirect 50,305 20.16 $1.01M 149,794 Form 4
2025-05-28 Salentine Thomas J JrDirector, 10% owner Saleindirect 651,454 20.16 $13.13M 1,939,817 Form 4
2025-05-28 Bindley William eDirector, 10% owner Saleindirect 651,454 20.16 $13.13M 1,939,817 Form 4
2025-05-27 Pharmacy Investors, LLCOther Sale 813,318 20.16 $16.40M 600,622 Form 4
2025-05-27 Cardinal Equity Fund, L.P.Other Sale 270,958 20.16 $5.46M 200,099 Form 4
2025-05-27 Bindley Capital Partners I, LLC10% owner Sale 3,508,905 20.16 $70.74M 2,591,271 Form 4
2025-05-27 Forbes KendallSee Remarks Sale 350,058 20.16 $7.06M 268,897 Form 4
2025-05-27 Burke FredDirector, See Remarks Sale 747,102 20.16 $15.06M 551,724 Form 4
2025-05-27 Morris David KDirector, See Remarks Sale 369,212 20.16 $7.44M 283,042 Form 4
2025-05-27 Ackerman JohnDirector Saleindirect 813,318 20.16 $16.40M 600,622 Form 4
2025-05-27 Ackerman JohnDirector Saleindirect 270,958 20.16 $5.46M 200,099 Form 4
2025-05-27 Salentine Thomas J JrDirector, 10% owner Saleindirect 3,508,905 20.16 $70.74M 2,591,271 Form 4
2025-05-27 Bindley William eDirector, 10% owner Saleindirect 3,508,905 20.16 $70.74M 2,591,271 Form 4
2024-11-19 Cosler Steven DDirector Buy 7,000 21.22 $148,540 17,713 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

44 × option exercise10 × grant or award2 × gift
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-09-27 Towns DouglasSee Remarks Option exercise M +23,450 – 113,006 Form 4
2026-09-27 Bindley Capital Partners I, LLC10% owner, Other Option exercise M +6,100,175 – 16,669,666 Form 4
2026-09-27 Cardinal Equity Fund, L.P.Other Option exercise M +471,057 – 1,287,237 Form 4
2026-09-27 Eakins RichardSenior Vice President, Sales Option exercise M +36,052 – 134,930 Form 4
2026-09-27 Crisafulli ChrisSee Remarks Option exercise M +18,931 – 53,057 Form 4
2026-09-27 Morris David KDirector, See Remarks, Other Option exercise M +641,870 – 896,341 Form 4
2026-09-27 Bindley William eDirector, 10% owner, Other Option exercise M +6,100,175 – 16,669,666 Form 4
2026-09-27 Forbes KendallOther Option exercise M +608,570 – 1,651,059 Form 4
2026-09-27 Tuch JeffreySee Remarks Option exercise M +55,578 – 231,847 Form 4
2026-09-27 Burke FredDirector, See Remarks, Other Option exercise M +1,298,825 – 3,438,064 Form 4
2026-09-27 Pharmacy Investors, LLCOther Option exercise M +1,413,939 – 3,863,806 Form 4
2026-09-27 Martin David NormanSee Remarks Option exercise M +39,865 – 140,905 Form 4
2026-09-27 Salentine Thomas J JrDirector, 10% owner, Other Option exercise M +6,100,175 – 16,669,666 Form 4
2026-09-27 Ackerman JohnDirector, Other Option exercise M +1,413,939 – 3,863,806 Form 4
2026-09-27 Ackerman JohnDirector, Other Option exercise M +471,057 – 1,287,237 Form 4
2026-09-27 Weir RobertSee Remarks Option exercise M +23,450 – 103,333 Form 4
2026-09-27 Mudd William FranklinSee Remarks Option exercise M +38,282 – 136,747 Form 4
2026-05-05 Lewis Randall JDirector Grant or award A +4,028 – 15,071 Form 4
2026-05-05 Cosler Steven DDirector Grant or award A +4,028 – 29,012 Form 4
2026-05-05 Patchett Mary SueDirector Grant or award A +4,028 – 15,071 Form 4
2026-03-28 Burke FredDirector, See Remarks Option exercise M +1,298,826 – 2,139,239 Form 4
2026-03-28 Ackerman JohnDirector Option exercise M +1,413,939 – 2,449,867 Form 4
2026-03-28 Ackerman JohnDirector Option exercise M +471,057 – 816,180 Form 4
2026-03-28 Bindley Capital Partners I, LLC10% owner Option exercise M +6,100,175 – 10,569,491 Form 4
2026-03-28 Morris David KDirector, See Remarks Option exercise M +641,869 – 896,341 Form 4
2026-03-28 Forbes KendallSee Remarks Option exercise M +608,570 – 1,061,826 Form 4
2026-03-28 Salentine Thomas J JrDirector, 10% owner Option exercise M +6,100,175 – 10,569,491 Form 4
2026-03-28 Cardinal Equity Fund, L.P.Other Option exercise M +471,057 – 816,180 Form 4
2026-03-28 Bindley William eDirector, 10% owner Option exercise M +6,100,175 – 10,569,491 Form 4
2026-03-28 Pharmacy Investors, LLCOther Option exercise M +1,413,939 – 2,449,867 Form 4
2026-03-01 Forbes KendallSee Remarks Grant or award A +8,952 – 799,928 Form 4
2026-03-01 Morris David KDirector, See Remarks Grant or award A +8,952 – 442,327 Form 4
2025-12-04 Forbes KendallSee Remarks Gift G −21,500 – 790,976 Form 4
2025-12-04 Burke FredDirector, See Remarks Gift G −200,000 – 1,511,845 Form 4
2025-09-27 Burke FredDirector, See Remarks Option exercise M +1,298,826 – 1,711,845 Form 4
2025-09-27 Pharmacy Investors, LLCOther Option exercise M +1,413,940 – 1,863,564 Form 4
2025-09-27 Morris David KDirector, See Remarks Option exercise M +641,869 – 856,364 Form 4
2025-09-27 Bindley William eDirector, 10% owner Option exercise M +6,100,176 – 8,039,993 Form 4
2025-09-27 Salentine Thomas J JrDirector, 10% owner Option exercise M +6,100,176 – 8,039,993 Form 4
2025-09-27 Bindley Capital Partners I, LLC10% owner Option exercise M +6,100,176 – 8,039,993 Form 4
2025-09-27 Cardinal Equity Fund, L.P.Other Option exercise M +471,057 – 620,851 Form 4
2025-09-27 Forbes KendallSee Remarks Option exercise M +608,570 – 812,476 Form 4
2025-09-27 Ackerman JohnDirector Option exercise M +1,413,940 – 1,863,564 Form 4
2025-09-27 Ackerman JohnDirector Option exercise M +471,057 – 620,851 Form 4
2025-05-09 Lewis Randall JDirector Grant or award A +3,901 – 11,043 Form 4
2025-05-09 Patchett Mary SueDirector Grant or award A +3,901 – 11,043 Form 4
2025-05-09 Cosler Steven DDirector Grant or award A +3,901 – 21,614 Form 4
2025-03-28 Burke FredDirector, See Remarks Option exercise M +1,298,826 – 1,298,826 Form 4
2025-03-28 Salentine Thomas J JrDirector Option exercise M +6,100,176 – 6,100,176 Form 4
2025-03-28 Forbes KendallSee Remarks Option exercise M +608,570 – 618,955 Form 4
2025-03-28 Ackerman JohnDirector Option exercise M +1,413,940 – 1,413,940 Form 4
2025-03-28 Ackerman JohnDirector Option exercise M +471,057 – 471,057 Form 4
2025-03-28 Morris David KDirector, See Remarks Option exercise M +641,869 – 652,254 Form 4
2025-03-28 Bindley William eDirector, 10% owner Option exercise M +6,100,176 – 6,100,176 Form 4
2025-02-05 Morris David KDirector, See Remarks Grant or award A +10,385 – 10,385 Form 4
2025-02-05 Forbes KendallSee Remarks Grant or award A +10,385 – 10,385 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Guardian Pharmacy Services's scores and multiples ›